Locations:
Search
Strategies and risk models are evolving for this asymptomatic condition
Retrospective study involves 18 years of follow-up and shows low risk of local recurrence.
Large trial shows efficacy and lower incidences of heart issues and bleeding events with novel non-covalent BTK inhibitor
Patients with a prior history of VTA are at an increased risk of subsequent incidents, despite treatment with therapeutic anticoagulation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Single-cell next-gen sequencing showing promise to improve sensitivity of MRD testing
An innovative approach to protecting patients during breast and lung radiation therapy
Regular surveillance necessary to identify safety signals
Potential treatment option for patients who are ineligible for cisplatin
Blood-based assay could alleviate barriers to lung cancer screening
Radiomic nomogram helps clinicians assess risk in patients treated with stereotactic body radiation therapy
Advertisement
Advertisement